Gaudium IVF and Women Health Ltd (GAUDIUMIVF) — Board Meeting | 3 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Gaudium IVF's AGM approves director appointments, remuneration revisions, and appoints Suresh Nainwal & Company as secretarial auditors for five years.
🔄 What Changed
Remuneration for Dr. Peeyush Khanna and Dr. Manika Khanna revised with new effective dates and tenure; Suresh Nainwal & Company appointed as secretarial auditors for five years.
🔮 What's Next
None
💡 Investor Takeaway
Shareholders will vote on director reappointments and remuneration packages that could affect governance costs and investor perception of leadership stability.

Gaudium IVF and Women Health Ltd will hold its 11th AGM on September 28, 2026, via video conference, where shareholders will approve the adoption of audited standalone and consolidated financial statements, appoint Vishad Khanna as a director, revise remuneration for Whole-Time Directors Dr. Peeyush Khanna (₹48 lakhs salary + ₹36 lakhs consultancy fees effective October 1, 2026 to December 10, 2029) and Dr. Manika Khanna ([amount not verified] consultancy fees till September 19, 2027), and appoint Suresh Nainwal & Company as secretarial auditors for five years. The meeting will follow SEBI and MCA regulations with remote e-voting available from September 25 to 27, 2026, requiring demat shareholders to submit DPID-CLID, PAN, and Aadhaar for access.

📄 View Original Announcement (PDF)

About Gaudium IVF and Women Health Ltd (GAUDIUMIVF)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹861.07 Cr P/E: 31.9 ROE: 50.0% ROCE: 52.1%

View full GAUDIUMIVF stock details →

📡 Get AI alerts when GAUDIUMIVF files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GAUDIUMIVF — Free

📊 More GAUDIUMIVF filings

See all GAUDIUMIVF filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GAUDIUMIVF files new disclosures

Track GAUDIUMIVF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GAUDIUMIVF — Free

Free account · 2 AI queries/day